Inhibition of toxic metal-alpha synuclein interactions by human serum albumin
Karla Martinez Pomier,Rashik Ahmed,Jinfeng Huang,Giuseppe Melacini
DOI: https://doi.org/10.1039/d3sc06285f
IF: 8.4
2024-02-02
Chemical Science
Abstract:Human serum albumin (HSA), the most abundant protein in plasma and cerebrospinal fluid, not only serves as a crucial carrier of various exogenous and endogenous ligands but also modulates the aggregation of amyloidogenic proteins, including alpha synuclein (αSyn), which is associated with Parkinson's disease and other α-synucleinopathies. HSA decreases αSyn toxicity through the direct binding to monomeric and oligomeric αSyn species. However, it is possible that HSA also sequesters metal ions that otherwise promote aggregation. Cu( II ) ions, for example, enhance αSyn fibrillization in vitro , while also leading to neurotoxicity by generating reactive oxygen species (ROS). However, it is currently unclear if and how HSA affects Cu( II )-binding to αSyn. Using an integrated set of NMR experiments, we show that HSA is able to chelate Cu( II ) ions from αSyn more efficiently than standard chelators such as EDTA, revealing an unexpected cooperativity between the HSA metal-binding sites. Notably, fatty acid binding to HSA perturbs this cooperativity, thus interfering with the sequestration of Cu( II ) ions from αSyn. We also observed that glycation of HSA diminished Cu( II )-binding affinity, while largely preserving the degree of cooperativity between the HSA metal-binding sites. Additionally, our results show that Cu( II )-binding to HSA stabilizes the interactions of HSA with αSyn primarily at two different regions, i.e. the N-terminus, Tyr 39 and the majority of the C-terminus. Our study not only unveils the effect of fatty acid binding and age-related posttranslational modifications, such as glycation, on the neuroprotective mechanisms of HSA, but also highlights the potential of αSyn as a viable NMR-based sensor to investigate HSA-metal interactions.
chemistry, multidisciplinary